BMY vs JNJ
BMY and JNJ side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BMYBRISTOL-MYERS SQUIBB COMPANY | JNJJohnson & Johnson |
|---|---|---|
| Market cap | $127.69B | $657.80B |
| P/E (TTM) | 13.9 | 41.5 |
| P/B | 5.46 | 8.07 |
| P/S | 2.6x | 7.0x |
| Dividend yield | 3.95% | 1.88% |
| Revenue | $50.03B(TTM) | $99.33B(TTM) |
| Revenue growth (YoY) | -0.2% | 6.0% |
| Net income | $9.24B(TTM) | $16.09B(TTM) |
| Earnings growth (YoY) | 178.8% | 90.6% |
| EPS, diluted | $4.51(TTM) | $6.58(TTM) |
| EBIT margin | 21.8% | 22.9% |
| ROE | 30.1% | 32.9% |
| ROIC | 14.0% | 16.3% |
| Piotroski F | 7/9 | 6/9 |
| 1y total return | +42.3% | +47.3% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BMY vs JNJ
| Metric | BMY | JNJ |
|---|---|---|
| End value | $12.3K | $30.2K |
| Total return | +23.0% | +202.5% |
| CAGR | +2.0% | +11.3% |
| Volatility | 25.4% | 18.8% |
| Sharpe | 0.04 | 0.44 |
| Sortino | 0.06 | 0.63 |
| Max drawdown | -47.7% | -27.4% |
Based on 2600 common trading days, 2016-06-29 → 2026-10-30 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)